IAM Patent 1000 2023

Patents are essential business commodities and knowing how to obtain, enforce and monetise them has become mission critical. The IAM Patent 1000 has firmly established itself as the definitive ‘go-to’ resource for those seeking to identify world-class, private practice patent expertise.

Israel

Ranking 16th in the Global Innovation Index 2022, Israel continues to lead the region when it comes to creative and technology-driven outputs. The Israeli market has consistently matured and is open more than ever to foreign companies and investment, particularly in the pharmaceutical and medical industries. However, Chinese investment in...

Read more

Ranking 16th in the Global Innovation Index 2022, Israel continues to lead the region when it comes to creative and technology-driven outputs. The Israeli market has consistently matured and is open more than ever to foreign companies and investment, particularly in the pharmaceutical and medical industries. However, Chinese investment in the country has plateaued since its peak in 2018. The multiple electoral changes in recent years have led to a stagnation in legislative changes, which has affected the patent world. Nevertheless, in August 2022 the Israeli parliament approved a bill amending the Patents Law, which aimed to introduce statistical process control manufacturing and stockpiling waivers. The amendment intends to increase competition in the Israeli pharmaceutical industry to become more aligned with international markets, particularly within the European Union. Some practitioners worry about the potential impact of this amendment on pharmaceutical patents.

Show less

Unlock unlimited access to all IAM content